×
TransMedics EBIT 2019-2024 | TMDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TransMedics ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
TransMedics EBIT 2019-2024 | TMDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TransMedics ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216B
Thermo Fisher Scientific (TMO)
$205.7B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44.1B
IDEXX Laboratories (IDXX)
$37.1B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$34.2B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.6B
STERIS (STE)
$21.7B
SONOVA HOLDING (SONVY)
$19.3B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.5B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Masimo (MASI)
$9.5B
Glaukos (GKOS)
$8.7B
Teleflex (TFX)
$8.1B
Inari Medical (NARI)
$4.7B
Integer Holdings (ITGR)
$4.5B
PROCEPT BioRobotics (PRCT)
$3.4B
Veracyte (VCYT)
$3.2B
Nihon Kohden (NHNKY)
$2.7B
LivaNova (LIVN)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B
Pulse Biosciences (PLSE)
$1.2B